Biologic versus small molecule therapy for treating moderate to severe atopic dermatitis: clinical considerationsArticle Published on 2023-04-282024-09-04 Journal: The journal of allergy and clinical immunology. In [Category] 대상포진, [키워드] abrocitinib atopic dermatitis Baricitinib biologics cytokine signaling Dupilumab eczema interleukin-13 Interleukin-4 Janus kinase inhibitor lebrikizumab nemolizumab tralokinumab Upadacitinib [DOI] 10.1016/j.jaip.2023.03.011 PMC 바로가기 [Article Type] Article
Dupilumab-Induced, Tralokinumab-Induced, and Belantamab Mafodotin–Induced Adverse Ocular Events—Incidence, Etiology, and Managementarticle Published on 2023-04-152024-09-02 Journal: Cornea [Category] 대상포진, [키워드] belantamab mafodotin Dupilumab ocular surface disease tralokinumab [DOI] 10.1097/ICO.0000000000003162 PMC 바로가기 [Article Type] article